Clinical Investigator Award Recipients

These grants were made possible by the SSO Impact Fund. To learn more about the Fund or to donate, please visit this page.

Oliver Eng, MD

“Metabolic Therapy for Pseudomyxoma Peritonei”

This award was made possible by a grant from ACPMP

Emily Keung, MD

“Spatially Resolved Multiomics of Primary Soft Tissue Sarcomas and Their Matched Metastase”

This award was made possible by donors to The SSO Research and Education Fund

Neha Goel, MD

“Zip Code to Genomic Code: Social Genomic Mechanisms Linking Structural Racism, Perceived Discrimination, and Breast Cancer Survival”

This award was made possible by donors to The SSO Research and Education Fund

Heather Wachtel, MD

“PARP-1 as a Novel Theranostic Target in Pheochromocytoma and Paraganglioma”

This award was made possible by donors to The SSO Research and Education Fund

Carlos Chan, MD, PhD

“Clinical Translation of New Immunotherapy-based Concepts in Patients with Peritoneal Metastasis”

This award was made possible by donors to The SSO Research and Education Fund

Chukwuemeka Ihemelandu, MD

Evaluation of the Effect of Gut Microbiome Composition on Response of Colon Cancer Metastases to Systemic Therapy”

This award was made possible by donors to The SSO Research and Education Fund.

Christina Roland, MD, MS, FSSO

“Characterization of Intratumoral B cells and Microbiome to Enhance Responses to Sarcoma Immune Checkpoint Blockade”

This award was made possible by donors to The SSO Research and Education Fund.

Vikas Dudeja, MD

Evaluation of the Effect of Gut Microbiome Composition on Response of Colon Cancer Metastases to Systemic Therapy”

This award was made possible by donors to The SSO Research and Education Fund.

Ajay V. Maker, MD

Combination Immunotherapy to Treat Colon Cancer Metastases”

This award was made possible by donors to The SSO Research and Education Fund. 

Christina V. Angeles, MD FACS

Characterization of skin resident memory T cells in melanoma survivors”

*Supported by a grant from Amgen

Heather Neuman, MD, MS 

 “Understanding Socioeconomic Disparities in the Receipt of Post-Mastectomy Breast Reconstruction”

*Supported by an educational grant from Genentech, Inc.

Genevieve Boland, MD, PhD

“Tumor and Immune Monitoring via Exosomal Analysis in Patients on Targeted Therapy with Anti-PD1 Immunotherapy”

Supported by an educational grant from Amgen

Rebecca Gladdy, MD, PhD

“Metabolic Reprogramming in Sarcoma-Repurposing Statins as Anticancer Agents”

Supported by an educational grant from Genentech

Robert Canter, MD

“Radiation and Natural Killer Cell Immunotherapy to Target Tumor Heterogeneity in Canine Bone and Soft Tissue Sarcoma”

Supported by an educational grant from Genentech

Kelly Olino, MD

“Therapeutic Synthetic Peptide Nanofiber Vaccines Targeting Melanoma”

Supported by an educational grant from Amgen, Inc.

George Miller, MD

“Modulation of tumor-promoting influences of y&T cells in pancreatic carcinoma in a Phase II clinical trial utilizing perioperative gemcitabine + nab-paclitaxel”

Supported by an educational grant from Genentech

Ryan C. Fields, MD

“Identifying Novel Mechanisms of Metastases in Colorectal Cancer”

Supported by an educational grant from Genentech 

Stephen Grobmyer, MD

“The Microbiome and Human Breast Cancer”

Supported by an educational grant from Amgen

Swati Kulkarni, MD

“Bariatric surgery alters estradiol availability and estrogen receptor alpha activity in postmenopausal women”

Supported by an educational grant from Susan G. Komen for the Cure®

Jonathan Wright, MD  

“A Phase 1-2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients with Bladder Cancer”  

Supported by an educational grant from Amgen

Tina Yen, MD

“A population-based study of sentinel lymph mode biopsy adoption among breast cancer patients: Does efficacy translate to effectiveness?”

Supported by an educational grant from Genentech

Jacqueline S. Jeruss, MD

“Synergistic Action of Carboplatin/Eribulin in Combination with CDK Inhibitor Therapy for the Treatment of Triple Negative Cancer”

Supported by an educational grant from Susan G. Komen for the Cure®

Charlotte Eielson Ariyan, MD, PhD

“Combining CTLA-4 Blockade with Regional Chemotherapy to Augment Anti-Tumor Immunity in Melanoma”

Supported by an educational grant from Genentech

Jen Jen Yeh, MD

Proposal: “Circulating Tumor Cells as a Biomarker for Treatment Response in Patients with Pancreatic Cancer”

Supported by an educational grant from Amgen

Isabelle Bedrosian, MD

 “Assessment of the Interaction Between DNA Damage Response Pathway and IGF-1 Signaling in Predicting Breast Cancer Risk”

Supported by a grant from Susan G. Komen for the Cure®

Julie E. Lang, MD

“Isolation and Molecular Profiling of Circulating Tumor Cells in Breast Cancer”

Supported by an educational grant from Myriad Genetics

Steven C. Katz, MD

Clinical and Preclinical Evaluation of Regional Immunotherapy for Liver Metastases

Supported by an educational grant fromGenentech

Sunil Singhal, MD

 “Nanotechnology for Intraoperative Cancer Detection and Image-Guided Surgery”

Supported by an educational grant from Amgen

Clinical Investigator Award for Under-Represented (Black Indigenous People of Color/BIPOC) Surgeons

Chukwuemeka Ihemelandu, MD

Georgetown University

“Peptide-Based Imaging for Intraoperative Fluorescence-GuidedColorectal Cancer Surgery”

*Supported by a grant from Genentech, Inc.

For more on Dr. Ihemelandu and his research click here.

Scroll to Top